Form 4: Eli Lilly Executive Diogo Rau Acquires Restricted Stock Units

Eli Lilly's Executive Vice President and Chief Information and Digital Officer, Diogo Rau, acquired 3,269 restricted stock units on February 12, 2024.

Summary

• Diogo Rau, Executive Vice President and Chief Information and Digital Officer at Eli Lilly & Co, reported a transaction on February 12, 2024.
• The transaction involved the acquisition of 3,269 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Eli Lilly common stock each.
• The restricted stock units are exercisable on February 1, 2025, and expire on the same date.
• Following the transaction, Mr. Rau directly owns 3,269 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it indicates alignment of executive interests with the company's performance. It is not a major event, but it is a positive sign.

Positives

• The acquisition of restricted stock units by a high-ranking executive like Diogo Rau can be seen as a positive sign of confidence in the company's future performance.

Future Outlook

The restricted stock units will vest and become exercisable on February 1, 2025.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives acquire or dispose of company securities. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

• The granting of restricted stock units is a common practice among publicly traded companies to incentivize and retain key executives.
• Many pharmaceutical companies use similar compensation structures to align executive interests with shareholder value.
• The vesting period of approximately one year is also typical for such grants.

Stakeholder Impact

• The acquisition of restricted stock units by an executive can be seen positively by shareholders as it aligns management's interests with the company's long-term success.

Key Dates

Keywords

restricted stock units, insider trading, executive compensation, Diogo Rau, Eli Lilly, LLY